For the year ending 2025-12-31, NXGL made $11,421K in revenue. -$3,000K in net income. Net profit margin of -26.27%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues, net | 11,421 | 8,688 | ||
| Cost of revenues | 6,912 | 5,940 | ||
| Gross profit | 4,509 | 2,748 | ||
| Research and development | 2 | 78 | ||
| Selling, general and administrative | 7,859 | 6,224 | ||
| Total operating expenses | 7,861 | 6,302 | ||
| Loss from operations | -3,352 | -3,554 | ||
| Realized gain on investments in marketable securities | - | 68 | ||
| Change in fair value of warrant liability, net of warrant modification expense | 118 | -28 | ||
| Interest expense, net | 34 | 81 | ||
| Gain in spin-off of nexgelrx | 162 | - | ||
| Other expense | 73 | 4 | ||
| Change in fair value of contingent consideration | - | 18 | ||
| Other income | 286 | 98 | ||
| Total other income (expense), net | 459 | 91 | ||
| Loss before income taxes | -2,893 | -3,463 | ||
| Net loss | -2,893 | -3,463 | ||
| Less loss attributable to non-controlling interest in joint venture | 107 | -182 | ||
| Net loss attributable to nexgel stockholders | -3,000 | -3,281 | ||
| Basic EPS | -0.38 | -0.5 | ||
| Diluted EPS | -0.38 | -0.5 | ||
| Basic Average Shares | 7,854,288 | 6,511,574 | ||
| Diluted Average Shares | 7,854,288 | 6,511,574 | ||
NEXGEL, INC. (NXGL)
NEXGEL, INC. (NXGL)